1. Home
  2. ITCI vs NOV Comparison

ITCI vs NOV Comparison

Compare ITCI & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • NOV
  • Stock Information
  • Founded
  • ITCI 2002
  • NOV 1862
  • Country
  • ITCI United States
  • NOV United States
  • Employees
  • ITCI N/A
  • NOV N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • NOV Metal Fabrications
  • Sector
  • ITCI Health Care
  • NOV Industrials
  • Exchange
  • ITCI Nasdaq
  • NOV Nasdaq
  • Market Cap
  • ITCI 8.0B
  • NOV 7.1B
  • IPO Year
  • ITCI N/A
  • NOV 1996
  • Fundamental
  • Price
  • ITCI $85.59
  • NOV $16.48
  • Analyst Decision
  • ITCI Strong Buy
  • NOV Buy
  • Analyst Count
  • ITCI 12
  • NOV 14
  • Target Price
  • ITCI $97.67
  • NOV $20.77
  • AVG Volume (30 Days)
  • ITCI 747.9K
  • NOV 3.8M
  • Earning Date
  • ITCI 10-30-2024
  • NOV 10-24-2024
  • Dividend Yield
  • ITCI N/A
  • NOV 1.85%
  • EPS Growth
  • ITCI N/A
  • NOV 114.38
  • EPS
  • ITCI N/A
  • NOV 2.70
  • Revenue
  • ITCI $613,728,000.00
  • NOV $8,905,000,000.00
  • Revenue This Year
  • ITCI $48.25
  • NOV $3.91
  • Revenue Next Year
  • ITCI $38.47
  • NOV $2.22
  • P/E Ratio
  • ITCI N/A
  • NOV $6.03
  • Revenue Growth
  • ITCI 46.08
  • NOV 7.12
  • 52 Week Low
  • ITCI $58.14
  • NOV $14.99
  • 52 Week High
  • ITCI $93.45
  • NOV $21.23
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 55.47
  • NOV 55.22
  • Support Level
  • ITCI $81.83
  • NOV $15.67
  • Resistance Level
  • ITCI $86.36
  • NOV $16.47
  • Average True Range (ATR)
  • ITCI 2.47
  • NOV 0.41
  • MACD
  • ITCI -0.76
  • NOV 0.04
  • Stochastic Oscillator
  • ITCI 30.64
  • NOV 67.66

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

Share on Social Networks: